EBITA tripled in H1
Lumibird''s H1 EBITA was EUR8.6m vs EUR2.9m in H1 20. This in our view is remarkable as H1 results were achieved in a context of gross margin decrease (down 320bps), notably due to mix. In spite of this, with sales growing by 65% (of which 35% due to scope effect) and by 13% on a pro-forma basis, the EBITA margin expanded from 6.3% in 2020 to 11.4% in H1 21, with Lumibird focusing heavily on opex control.
Medical margin increase impressive, Photonics healthy
The EBIT margi ....
22 Sep 2021
Robust margin improvement in medical
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Robust margin improvement in medical
EBITA tripled in H1
Lumibird''s H1 EBITA was EUR8.6m vs EUR2.9m in H1 20. This in our view is remarkable as H1 results were achieved in a context of gross margin decrease (down 320bps), notably due to mix. In spite of this, with sales growing by 65% (of which 35% due to scope effect) and by 13% on a pro-forma basis, the EBITA margin expanded from 6.3% in 2020 to 11.4% in H1 21, with Lumibird focusing heavily on opex control.
Medical margin increase impressive, Photonics healthy
The EBIT margi ....